Kairos Pharma, LTD.
KAPA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001962011
No open-market purchases or sales by Kairos Pharma, LTD. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $371.1K in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Kairos Pharma, LTD. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 5 | 8 | +3 |
| Shares | 406.6K | 1.58M | +1.17M (+287.9%) |
| Value | $618.3K | $1.46M | +$845.2K (+136.7%) |
New holders (5)
Institutions that held Kairos Pharma, LTD. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 1,404,000 | $1.31M | 0.04% |
| Scientech Research LLC | 48,198 | $45.1K | 0.01% |
| Aptus Capital Advisors, LLC | 44,286 | $41.5K | 0.00% |
| SevenBridge Financial Group, LLC | 44,286 | $28.3K | 0.01% |
| Geode Capital Management, LLC | 20,433 | $19.1K | 0.00% |
Sold out (2)
Institutions that held Kairos Pharma, LTD. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Umb Bank N A | 371,115 | $564.1K |
| Virtu Financial LLC | 13,656 | $21.0K |